Overview
Preoperative Regional Nerve Block for Acute and Chronic Post-Operative Pain Following Mastectomy
Status:
Recruiting
Recruiting
Trial end date:
2022-12-01
2022-12-01
Target enrollment:
0
0
Participant gender:
Female
Female
Summary
The purpose of this study is to see if pre-operative regional nerve blocks compared to a placebo nerve block can decrease chronic post mastectomy pain, immediate postoperative pain and postoperative narcotic consumption.Phase:
Early Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
University of Alabama at BirminghamTreatments:
Anesthetics
Bupivacaine
Criteria
Inclusion Criteria:1. Women at least 19 years old who are able to provide written and informed consent
2. Women undergoing unilateral or bilateral, simple, skin-sparing, or nipple sparing
mastectomy for breast cancer (Stage 0-III) or breast cancer prevention
3. Patients with ASA class of I-III will be included
Exclusion Criteria:
1. Stage IV breast cancer, morbid obesity with BMI >45kg/m2
2. Renal insufficiency (Creatinine >1.5 mg/dL)
3. Current chronic analgesic use (daily use for > or equal to 4 weeks)
4. History of opioid abuse or dependence
5. Presence of chronic pain with a self-reported average pain score of 4 or greater on a
pain scale of 0-10 prior to any surgical intervention
6. Incarceration
7. Pregnancy
8. Immediate autologous tissue reconstruction.